CD133 and non-small-cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 4, 2010, Pages 988-

  Wiwanitkit, Viroj ^a  

^a NONE   (Thailand)

Author keywords

CD133; Lung cancer

Indexed keywords

CD133 ANTIGEN;

CANCER PATIENT; CANCER STEM CELL; CANCER SURVIVAL; CELL INFILTRATION; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; TUMOR CELL; TUMOR VASCULARIZATION;

ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PEPTIDES;

EID: 77949485931     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.10.027     Document Type: Letter

References (4)

1. Tirino V., Camerlingo R., Franco R., Malanga D., La Rocca A., Viglietto G., Rocco G., and Pirozzi G. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg 36 (2009) 446-453
2. Hilbe W., Dirnhofer S., Oberwasserlechner F., Schmid T., Gunsilius E., Hilbe G., Wöll E., and Kähler C.M. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57 September (9) (2004) 965-969
3. Salnikov A.V., Gladkich J., Moldenhauer G., Volm M., Mattern J., and Herr I. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients. Int J Cancer August (2009) [Epub ahead of print]
4. Meng X., Li M., Wang X., Wang Y., and Ma D. Both CD133+ and CD133-subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci 100 June (6) (2009) 1040-1046